FindTrial
Sign In

Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004%

Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004%

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00347802
Enrollment
Unknown
Registered
2006-07-04
Start date
Unknown
Completion date
Unknown
Last updated
2007-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Brief summary

To compare the diurnal curves in patients using bimatoprost 0.03% versus travoprost 0.004% for the treatment of glaucoma or ocular hypertension.

Interventions

DRUGBimatoprost 0.03%, Travoprost 0.004%

Sponsors

Innovative Medical
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
SINGLE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* · Male or female \> 18 years of age * Naive to treatment or washed off any ocular hypotensive agents * Untreated IOP \>19 mm Hg * Diagnosis of open-angle glaucoma or ocular hypertension * Ability to provide informed consent and likely to complete study

Exclusion criteria

* · Known contraindication to bimatoprost or travoprost, or any component of any study medication * Uncontrolled systemic disease * Active ocular disease other than glaucoma or ocular hypertension * Required use of ocular medications other than the study medications during the study * History of intraocular surgery within the last 3 months * Prior discontinuation of any of the study medications for reasons related to efficacy or safety

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026